Publication
Legal strategies to tackle fraud in early-stage investments in Asia
In the wake of the recent eFishery scandal early-stage investors are recalibrating their approach to due diligence and risk tolerance.
Global | Publication | November 2018
Pharmaceutial and Medical Device Law, published by the ABA Health Law Section and Bloomberg BNA, provides readers with an overview of key legal and regulatory issues that impact the development and marketing activities of pharmaceutical and medical device companies.
Carol Poindexter, Paul Sumilas and Vijay Rao have contributed to Chapter 8 (Federal Sentencing Guidelines and Compliance Measures), which covers topics such as
Publication
In the wake of the recent eFishery scandal early-stage investors are recalibrating their approach to due diligence and risk tolerance.
Publication
As we stand on the cusp of transformative change within the energy sector, anticipation builds around the UK government’s impending decision on the Review of Electricity Market Arrangements (REMA). This briefing provides a recap of the proposals made to date and looks at the potential future impact of the REMA proposals on market players.
Publication
Antitrust authorities are increasingly aggressive in pursuing new theories of harm, pushing the boundaries of what amounts to an antitrust violation, and expanding the use of current legislation and regulation to fit a new era of issues.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025